ORCL Stock Analysis: Oracle | NYSE
Software - Infrastructure | NYSE, USA | Market Cap: 439.157m USD | 12M Return: -29.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.71B
EPS Trend: 89.7%
Qual. Beats: 1
Rev. Trend: 96.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
Average return per month, with how dependable it is below — did the month move the same way every year (high) or randomly (low). Above 60 is a pattern worth trusting; under 40 is noise.
Oracle Corporation (NYSE: ORCL) is an enterprise software and cloud computing company that provides a broad portfolio of products spanning software-as-a-service (SaaS), cloud and on-premise licenses, infrastructure technologies, and hardware. Its cloud applications cover core business functions including enterprise resource planning (ERP), supply chain management, human capital management, financial performance, customer experience, and healthcare, alongside industry-specific solutions. The company also sells database and middleware technologies, including the Oracle Database, MySQL, and Java, as well as engineered hardware systems, storage, and related support and consulting services.
Oracle operates primarily in the Information Technology sector (GICS Sub Industry: Systems Software), serving businesses, government agencies, and educational institutions through both direct sales and indirect channels. Founded in 1977 and headquartered in Austin, Texas, Oracle has been publicly traded since its 1986 IPO and maintains a strategic alliance with Metron, Inc. Its business model is anchored in recurring revenue from cloud subscriptions and license support, supplemented by hardware sales and professional services.
- OCI cloud revenue accelerates on AI workload demand
- Legacy database license revenue continues declining
- Cerner healthcare segment margins face ongoing pressure
| Net Income: 17.1b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.09 > 0.02 and ΔFCF/TA -8.81 > 1.0 |
| NWC/Revenue: 7.13% < 20% (prev -14.05%; Δ 21.18% < -1%) |
| CFO/TA 0.12 > 3% & CFO 32.0b > Net Income 17.1b |
| Net Debt (151b) to EBITDA (32.1b): 4.70 < 3 |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.92b) vs 12m ago 1.53% < -2% |
| Gross Margin: 65.81% > 18% (prev 70.51%; Δ -4.70% > 0.5%) |
| Asset Turnover: 31.32% > 50% (prev 34.09%; Δ -2.77% > 0%) |
| Interest Coverage Ratio: 5.25 > 6 (EBIT TTM 24.2b / Interest Expense TTM 4.60b) |
| A: 0.02 (Total Current Assets 46.6b - Total Current Liabilities 41.8b) / Total Assets 262b |
| B: -0.02 (Retained Earnings -4.31b / Total Assets 262b) |
| C: 0.11 (EBIT TTM 24.2b / Avg Total Assets 215b) |
| D: 0.19 (Book Value of Equity 42.5b / Total Liabilities 219b) |
| Altman-Z'' = 1.03 = BB |
| DSRI: 1.03 (Receivables 10.4b/8.56b, Revenue 67.4b/57.4b) |
| GMI: 1.07 (GM 70.51% / 65.81%) |
| AQI: 0.55 (AQ_t 0.33 / AQ_t-1 0.60) |
| SGI: 1.17 (Revenue 67.4b / 57.4b) |
| TATA: -0.06 (NI 17.1b - CFO 32.0b) / TA 262b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of June 30, 2026, the stock is trading at USD 147.76 with a total of 33,989,000 shares traded. Over the past week, the price has changed by -19.40%, over one month by -23.07%, over three months by +4.37% and over the past year by -29.51%.
Current recommended Stop Loss: 128.90 (which is 12.8% or 1.7 ATR below the current price).
Oracle has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy ORCL.
- StrongBuy: 20
- Buy: 4
- Hold: 15
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 252.6 | 71% |
P/E Trailing = 26.1959
P/E Forward = 18.8679
P/S = 6.5198
P/B = 11.694
P/EG = 0.8616
Revenue TTM = 67.4b USD
EBIT TTM = 24.2b USD
EBITDA TTM = 32.1b USD
Long Term Debt = 122b USD (from longTermDebt, last quarter)
Short Term Debt = 7.20b USD (from shortTermDebt, last quarter)
Debt = 183b USD (from shortLongTermDebtTotal, last quarter) + Leases 26.6b
Net Debt = 151b USD (calculated: Debt 183b - CCE 31.9b)
Enterprise Value = 590b USD (439b + Debt 183b - CCE 31.9b)
Interest Coverage Ratio = 5.25 (Ebit TTM 24.2b / Interest Expense TTM 4.60b)
EV/FCF = -24.91x (Enterprise Value 590b / FCF TTM -23.7b)
FCF Yield = -4.01% (FCF TTM -23.7b / Enterprise Value 590b)
FCF Margin = -35.16% (FCF TTM -23.7b / Revenue TTM 67.4b)
Net Margin = 25.37% (Net Income TTM 17.1b / Revenue TTM 67.4b)
Gross Margin = 65.81% ((Revenue TTM 67.4b - Cost of Revenue TTM 23.0b) / Revenue TTM)
Gross Margin QoQ = 65.18% (prev 64.56%)
Tobins Q-Ratio = 2.25 (Enterprise Value 590b / Total Assets 262b)
Interest Expense / Debt = 2.51% (Interest Expense 4.60b / Debt 183b)
Taxrate = 12.59% (2.47b / 19.6b)
NOPAT = 21.1b (EBIT 24.2b * (1 - 12.59%))
Current Ratio = 1.12 (Total Current Assets 46.6b / Total Current Liabilities 41.8b)
Debt / Equity = 4.30 (Debt 183b / totalStockholderEquity, last quarter 42.5b)
Debt / EBITDA = 4.70 (Net Debt 151b / EBITDA 32.1b)
Debt / FCF = -6.37 (negative FCF - burning cash) (Net Debt 151b / FCF TTM -23.7b)
Total Stockholder Equity = 33.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.95% (Net Income 17.1b / Total Assets 262b)
RoE = 50.59% (Net Income TTM 17.1b / Total Stockholder Equity 33.8b)
RoCE = 15.47% (EBIT 24.2b / Capital Employed (Equity 33.8b + L.T.Debt 122b))
RoIC = 9.43% (NOPAT 21.1b / Invested Capital 224b)
WACC = 9.80% (E(439b)/V(622b) * Re(12.96%) + D(183b)/V(622b) * Rd(2.51%) * (1-Tc(0.13)))
Discount Rate = 12.96% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 86.67 | Cagr: 1.50%
[DCF] Fair Price = unknown (Cash Flow -23.7b)
EPS Correlation: 89.75 | EPS CAGR: 6.38% | SUE: 0.96 | # QB: 1
Revenue Correlation: 96.91 | Revenue CAGR: 10.00% | SUE: 0.71 | # QB: 0
EPS current Quarter (2026-08-31): EPS=1.72 | Chg30d=+2.54% | Revisions=+0% | Analysts=33
EPS next Quarter (2026-11-30): EPS=1.88 | Chg30d=+2.57% | Revisions=+33% | Analysts=33
EPS current Year (2027-05-31): EPS=8.03 | Chg30d=+0.06% | Revisions=+40% | GrowthEPS=+5.3% | GrowthRev=+32.1%
EPS next Year (2028-05-31): EPS=10.88 | Chg30d=+1.60% | Revisions=-9% | GrowthEPS=+35.5% | GrowthRev=+45.7%
[Analyst] Revisions Ratio: +40%